CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 162 filers reported holding CLOVIS ONCOLOGY INC in Q4 2019. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $133,000 | -37.3% | 12,713 | -76.5% | 0.00% | -50.0% |
| Q3 2019 | $212,000 | +7.1% | 53,984 | +306.2% | 0.00% | 0.0% |
| Q2 2019 | $198,000 | -40.0% | 13,291 | 0.0% | 0.00% | -33.3% |
| Q1 2019 | $330,000 | -94.2% | 13,291 | -95.8% | 0.00% | -95.2% |
| Q4 2018 | $5,675,000 | -20.1% | 315,958 | +30.7% | 0.06% | +16.7% |
| Q3 2018 | $7,099,000 | +67.0% | 241,729 | +158.5% | 0.05% | +45.9% |
| Q2 2018 | $4,251,000 | -8.7% | 93,502 | +6.1% | 0.04% | -14.0% |
| Q1 2018 | $4,655,000 | +20.1% | 88,163 | +54.6% | 0.04% | +30.3% |
| Q4 2017 | $3,877,000 | +15.7% | 57,012 | +40.2% | 0.03% | +10.0% |
| Q3 2017 | $3,351,000 | -33.8% | 40,669 | -24.8% | 0.03% | -38.8% |
| Q2 2017 | $5,064,000 | +1205.2% | 54,089 | +740.3% | 0.05% | +716.7% |
| Q4 2013 | $388,000 | – | 6,437 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |